Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03363373
Brief Title: Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

First Submitted : November 6, 2017
First Submitted that Met QC Criteria : December 5, 2017
First Posted : December 6, 2017

Last Update Submitted that Met QC Criteria : March 6, 2019
Last Update Posted : March 8, 2019